Opaganib
Cat.No:IO0980 Solarbio
CAS:915385-81-8
Molecular Formula:C23H25ClN2O
Molecular Weight:380.91
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Immunology & Inflammation >
OpaganibCAS:915385-81-8
Molecular Formula:C23H25ClN2O
Molecular Weight:380.91
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 915385-81-8 |
Name | Opaganib |
Molecular Formula | C23H25ClN2O |
Molecular Weight | 380.91 |
Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD22666355 |
SMILES | O=C(C1(C2)CC3(C4=CC=C(Cl)C=C4)CC2CC(C3)C1)NCC5=CC=NC=C5 |
Target Point | sphingosine kinase-2 (SphK2) |
Passage | Immunology & Inflammation |
Background | Opaganib is a selective and competitive inhibitor of sphingosine kinase-2 (SphK2). |
Biological Activity | Opaganib (ABC294640)是一种口服生物可利用的选择性sphingosine kinase-2 (SphK2)抑制剂,IC50约为 60 μM。[1-4] |
Data Literature Source | [1] French KJ,et al. J Pharmacol Exp Ther. 2010,333(1),129-139. [2] Beljanski V,et al. J Pharmacol Exp Ther. 2010,333(2),454-464. [3] Antoon JW,et al. Endocrinology. 2010,151(11),5124-5135. [4] Liu Q,et al. PLoS One. 2012,7(7),e41834. |
Unit | Bottle |
Specification | 2mg 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.